Cargando…
Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism
Bawei Chenxiang Wan (BCW), a well-known traditional Chinese Tibetan medicine formula, is effective for the treatment of acute and chronic cardiovascular diseases. In the present study, we investigated the effect of BCW in cardiac hypertrophy and underlying mechanisms. The dose of 0.2, 0.4, and 0.8 g...
Autores principales: | Zhang, Xiaoying, Zhang, Zhiying, Wang, Pengxiang, Han, Yiwei, Liu, Lijun, Li, Jie, Chen, Yichun, Liu, Duxia, Wang, Jinying, Tian, Xiaoying, Zhao, Qin, Yan, Fengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209424/ https://www.ncbi.nlm.nih.gov/pubmed/34149410 http://dx.doi.org/10.3389/fphar.2021.653901 |
Ejemplares similares
-
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway
por: Wang, Hui‐Bo, et al.
Publicado: (2019) -
Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021) -
Thymoquinone ameliorates pressure overload‐induced cardiac hypertrophy by activating the AMPK signalling pathway
por: Chen, Heng, et al.
Publicado: (2021) -
Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy
por: Gao, Maomao, et al.
Publicado: (2020) -
Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization
por: Yan, Shuguang, et al.
Publicado: (2022)